Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand… Read more
Sofwave Medical Ltd (SOFW) - Net Assets
Latest net assets as of September 2025: ILA28.01 Million ILA
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has net assets worth ILA28.01 Million ILA as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA46.96 Million) and total liabilities (ILA18.95 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA28.01 Million |
| % of Total Assets | 59.65% |
| Annual Growth Rate | N/A |
| 5-Year Change | 1499.87% |
| 10-Year Change | N/A |
| Growth Volatility | 1190.62 |
Sofwave Medical Ltd - Net Assets Trend (2018–2024)
This chart illustrates how Sofwave Medical Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sofwave Medical Ltd (2018–2024)
The table below shows the annual net assets of Sofwave Medical Ltd from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA24.53 Million | -6.90% |
| 2023-12-31 | ILA26.34 Million | -18.54% |
| 2022-12-31 | ILA32.34 Million | -30.75% |
| 2021-12-31 | ILA46.70 Million | +2946.44% |
| 2020-12-31 | ILA1.53 Million | -62.75% |
| 2019-12-31 | ILA4.12 Million | +759.46% |
| 2018-12-31 | ILA-624.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sofwave Medical Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5431000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA2.00K | 0.01% |
| Other Comprehensive Income | ILA14.06 Million | 57.34% |
| Other Components | ILA68.49 Million | 279.24% |
| Total Equity | ILA24.53 Million | 100.00% |
Sofwave Medical Ltd Competitors by Market Cap
The table below lists competitors of Sofwave Medical Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BIG Industries Bhd
KLSE:7005
|
$3.18 Million |
|
Zhengye Biotechnology Holding Limited Ordinary Shares
NASDAQ:ZYBT
|
$3.18 Million |
|
K2 Asset Management Holdings Ltd
AU:KAM
|
$3.18 Million |
|
Afrimat
JSE:AFT
|
$3.19 Million |
|
P3 Health Partners Inc
NASDAQ:PIII
|
$3.18 Million |
|
Indah Prakasa Sentosa PT Tbk
JK:INPS
|
$3.18 Million |
|
Restaurant Brands New Zealand Limited
PINK:RTBRF
|
$3.18 Million |
|
JBDI Holdings Limited Ordinary Shares
NASDAQ:JBDI
|
$3.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sofwave Medical Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 26,343,000 to 24,526,000, a change of -1,817,000 (-6.9%).
- Net loss of 4,546,000 reduced equity.
- New share issuances of 326,000 increased equity.
- Other comprehensive income increased equity by 1,137,000.
- Other factors increased equity by 1,266,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-4.55 Million | -18.54% |
| Share Issuances | ILA326.00K | +1.33% |
| Other Comprehensive Income | ILA1.14 Million | +4.64% |
| Other Changes | ILA1.27 Million | +5.16% |
| Total Change | ILA- | -6.90% |
Book Value vs Market Value Analysis
This analysis compares Sofwave Medical Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5089.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 20500.77x to 5089.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ILA0.18 | ILA3637.00 | x |
| 2020-12-31 | ILA0.04 | ILA3637.00 | x |
| 2021-12-31 | ILA1.99 | ILA3637.00 | x |
| 2022-12-31 | ILA0.95 | ILA3637.00 | x |
| 2023-12-31 | ILA0.77 | ILA3637.00 | x |
| 2024-12-31 | ILA0.71 | ILA3637.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sofwave Medical Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -18.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -7.62%
- • Asset Turnover: 1.39x
- • Equity Multiplier: 1.75x
- Recent ROE (-18.54%) is above the historical average (-161.84%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -83.72% | -1239.21% | 0.04x | 1.51x | ILA-3.86 Million |
| 2020 | -762.36% | -272.36% | 0.89x | 3.14x | ILA-11.84 Million |
| 2021 | -14.62% | -31.26% | 0.36x | 1.30x | ILA-11.50 Million |
| 2022 | -60.39% | -54.81% | 0.77x | 1.42x | ILA-22.76 Million |
| 2023 | -31.42% | -16.45% | 1.16x | 1.65x | ILA-10.91 Million |
| 2024 | -18.54% | -7.62% | 1.39x | 1.75x | ILA-7.00 Million |
Industry Comparison
This section compares Sofwave Medical Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $47,827,667
- Average return on equity (ROE) among peers: -2.53%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sofwave Medical Ltd (SOFW) | ILA28.01 Million | -83.72% | 0.68x | $3.18 Million |
| Allmed Solutions Ltd (ALMD) | $45.13 Million | -46.38% | 0.26x | $96.61K |
| Erika Carmel Ltd (BCUR) | $8.97 Million | 138.94% | 4.32x | $46.92K |
| Bio-View Ltd (BIOV) | $23.45 Million | -5.34% | 0.48x | $54.59K |
| Erech Finance Cahalacha Ltd (EFNC) | $-63.00K | 0.00% | 0.00x | $19.28K |
| Endymed (ENDY) | $14.70 Million | 5.78% | 0.34x | $118.10K |
| Epitomee Medical Ltd (EPIT) | $34.80 Million | -16.33% | 0.16x | $567.43K |
| Human Xtensions Ltd (HUMX) | $61.78 Million | -72.18% | 0.17x | $21.16K |
| Ilex Medical (ILX) | $109.44 Million | 17.00% | 0.55x | $2.01 Million |
| Pulsenmore Ltd (PULS) | $132.23 Million | -44.29% | 0.36x | $321.83K |